Zacks Investment Research on MSN
PLSE accelerates cardiac catheter program after breakthrough AFib data
Pulse Biosciences PLSE recently announced a strategic shift aimed at accelerating the development and future ...
A new study published in the Journal of American Medical Association showed that adding catheter ablation to conventional ...
Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...
Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation, catheter ablation reduces anxiety and depression symptoms better than ...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation ...
Please provide your email address to receive an email when new articles are posted on . The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among ...
Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...
Researchers conducted a retrospective cohort study comparing the efficacy of first-time catheter ablation between young and older adults with AF who underwent the procedure between 2016 and 2023. The ...
A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements ...
Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results